BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24998254)

  • 1. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
    Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
    Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy.
    Li MH; Zhang YJ; Yu YH; Yang SH; Iqbal J; Mi QY; Li B; Wang ZM; Mao WX; Xie HG; Chen SL
    Eur J Pharmacol; 2014 Apr; 728():67-76. PubMed ID: 24508518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
    Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
    Ma W; Liang F; Zhan H; Jiang X; Gao C; Zhang X; Zhang K; Sun Q; Hu H; Zhao Z
    Acta Physiol (Oxf); 2020 Oct; 230(2):e13519. PubMed ID: 32480429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR30 Alleviates Pressure Overload-Induced Myocardial Hypertrophy in Ovariectomized Mice by Regulating Autophagy.
    Zhang S; Ma J; Wang X; Zhao D; Zhang J; Jiang L; Duan W; Wang X; Hong Z; Li Z; Liu J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
    Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
    Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2015 Aug; 19(8):1929-38. PubMed ID: 25946687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor, mocetinostat, regulates cardiac remodelling and renin-angiotensin system activity in rats with transverse aortic constriction-induced pressure overload cardiac hypertrophy.
    Kim GJ; Jung H; Lee E; Chung SW
    Rev Cardiovasc Med; 2021 Sep; 22(3):1037-1045. PubMed ID: 34565105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
    Cheng WP; Lo HM; Wang BW; Chua SK; Shyu KG
    J Cell Mol Med; 2019 Feb; 23(2):1406-1414. PubMed ID: 30511410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autophagic flux of cardiomyocytes from 20-week transverse abdominal aortic constriction rats].
    Cui LB; Sheng JJ; Wang YY; Yu ZB
    Sheng Li Xue Bao; 2013 Jun; 65(3):301-8. PubMed ID: 23788187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant N-acetylcysteine inhibits maladaptive myocyte autophagy in pressure overload induced cardiac remodeling in rats.
    Li B; Sun Y; Wang JP; Chi RF; Wang K; Yang ZJ; Qin FZ; Fan B
    Eur J Pharmacol; 2018 Nov; 839():47-56. PubMed ID: 30194941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic exercise ameliorates cardiac hypertrophy by regulating mitochondrial quality control and endoplasmic reticulum stress through M
    Ma M; Chen W; Hua Y; Jia H; Song Y; Wang Y
    J Cell Physiol; 2021 Sep; 236(9):6581-6596. PubMed ID: 33615478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
    Liu W; Zi M; Tsui H; Chowdhury SK; Zeef L; Meng QJ; Travis M; Prehar S; Berry A; Hanley NA; Neyses L; Xiao RP; Oceandy D; Ke Y; Solaro RJ; Cartwright EJ; Lei M; Wang X
    Circ Heart Fail; 2013 Jul; 6(4):833-44. PubMed ID: 23753531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.